7月 2026
- 首頁
- Delcath Systems
7月 2026Delcath Systems的市場佔有率分析
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
Delcath Systems(包含公司地區)
查看更多網站流量與參與度資訊- delcath.com
Delcath Systems截至 7月 2026 的總收入為 75M - 100M
Delcath Systems 熱門網域產生的總收入
Delcath Systems 熱門網域 3 年內的總收入
Delcath Systems 熱門網域的總收入
Delcath Systems的熱門網域總造訪量
了解Delcath Systems市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Delcath Systems的熱門網域平均造訪時長
分析Delcath Systems參與度指標。
過去 3 個月平均造訪時長
子公司細目
Delcath Systems的熱門網域平均頁面瀏覽量
了解Delcath Systems如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Delcath Systems
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Delcath Systems, Inc. expanded facilities to New York, 12804, United States, Northern America, Americas on Aug 1st '26.Delcath Systems Inc. (Nasdaq: DCTH) recently obtained approvals from the town of Kingsbury to expand its facility at 566 Queensbury Ave. near Floyd Bennett Memorial Airport."
8月 21, 2026閱讀更多
新聞Delcath Systems, Inc. signed new client UVA Health on Jul 1st '23.The new treatment that U.Va. Health is offering - Hepzato - is a delivery system developed by Delcath Systems, an interventional oncology company, and it was approved by the Food and Drug Administration in 2023.
7月 1, 2026閱讀更多
新聞Delcath Systems, Inc. receives award Patient Impact Award at Life Science Industry Awards 2026.Meanwhile, the Patient Impact Award went to Delcath Systems Ltd, based at Mervue Business Park
6月 4, 2026閱讀更多
查看所有Delcath Systems信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
